Table 5.
Cannabis use |
|||||||
---|---|---|---|---|---|---|---|
Best fitting model | Bivariate a2 | Bivariate c2 | Bivariate e2 | ra | rc | re | |
Paranoia | ACE dropped ra | – | 0.72 (0.55, 0.88) | 0.28 (0.12, 0.45) | – | 0.76 (0.40, 1.00) | 0.31 (0.13, 0.48) |
Hallucinations | ACE | 0.54 (−0.35, 1.47) | 0.33 (−0.48, 1.10) | 0.13 (−0.13, 0.40) | 0.29 (−0.19, 0.78) | 0.17 (−0.24, 0.57) | 0.11 (−0.10, 0.31) |
Cognitive disorganization | ACE dropped ra | – | 0.69 (0.47, 0.88) | 0.31 (0.12, 0.53) | – | 0.49 (0.24, 1.00) | 0.26 (0.09, 0.42) |
Parent-rated negative symptoms | ACE dropped ra | – | 1.00 (0.85, 1.19) | 0.00 (−0.19, 0.15) | – | 0.31 (0.18, 0.46) | 0.00 (−0.23, 0.21) |
Note: ACE=full model testing genetic, common and unique environmental influences; ACE dropped ra=full model testing genetic, common and unique environmental influences with genetic correlation fixed to 0; bivariate genetic (bivariate a2), common environment (bivariate c2) and unique environment (bivariate e2) estimated indicate the proportion of phenotypic correlations explained by genetics, common and unique environment, respectively. Bivariate genetic (ra), common environment (rc) and unique environment (re) correlations indicate the genetic and environmental overlap between psychotic symptoms and cannabis use. A correlation of ‘0’ is indicative of no overlap and a correlation of ‘1’ is indicative of complete overlap in either genetic or environmental influences. 95% confidence intervals in parentheses.